What Is The Long-Term Forecast For The Global Lisinopril Market Growing At 5.9% CAGR?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Lisinopril Industry By 2029?
In recent times, the lisinopril market has seen robust growth. The market, which is set to swell from $1.76 billion in 2024 to $1.87 billion in 2025, will do so at a compound annual growth rate (CAGR) of 6.4%. Factors that have contributed to the market’s growth during the historical period include improved accessibility, changes in lifestyle, a rise in screening programs, an increase in the availability of generic lisinopril, and higher patient compliance.
In the coming years, a substantial increase is forecasted for the Lisinopril market, which is expected to inflate to $2.35 billion by 2029. This upward trend corresponds to an annual compound growth rate (CAGR) of 5.9%. The expansion during this forthcoming period is attributed to factors such as the increasing incidence of hypertension and cardiovascular complications, availability of generic versions, cost-efficiency, heightened awareness and early detection, escalating demand for potent treatments, and the expanding aged population. The forecast period is also likely to witness key trends such as advancements in drug delivery, the necessity for superior and patient-centered drug delivery methods, a desire for affordable solutions, a high demand for effective heart failure treatments, and effective treatments for diabetic kidney conditions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp
Which Factors Are Steering Growth In The Lisinopril Market?
The surge in incidences of cardiovascular diseases is anticipated to fuel the expansion of the lisinopril market. Cardiovascular diseases (CVDs), which encompass various disorders affecting the heart and blood vessels, are seeing an increase in prevalence due to several factors such as population growth and aging, risk factors, and inadequate adoption of proven prevention and treatment strategies. Lisinopril plays a significant role in managing cardiovascular diseases primarily by reducing blood pressure and alleviating strain on the heart and kidneys. It inhibits angiotensin II production, enables blood vessels to dilate, reduces blood volume, and offers organ protection. For example, the Singapore Heart Foundation (SHF), a non-profit organization in Singapore, reported that ischemic heart diseases led to 5,302 deaths in May 2024, a slight increase from the 5,290 deaths in 2022. Therefore, the rising incidences of cardiovascular diseases are propelling the growth of the lisinopril market.
Which Segment Accounts For The Largest Share In The Lisinopril Market?
The lisinoprilmarket covered in this report is segmented –
1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
3) By Dosage: Tablet; Liquid; Other Dosages
4) By Population Type: Children; Adults
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Zestoretic: Different Dosage Forms; Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms; Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms; Generic Versions Of Zestril
4) By Other Brands: International Brand Variants; Combination Drug Formulations
Who Are The Dominant Players In The Lisinopril Market Today?
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report
What Regional Factors Are Accelerating Growth In The Lisinopril Market?
North America was the largest region in the lisinopril market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16465&type=smp
Browse Through More Reports Similar to the Global Lisinopril Market 2025, By The Business Research Company
Automotive Collision Repair Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/automotive-collision-repair-global-market-report
Collision Avoidance System Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/collision-avoidance-system-global-market-report
Forward Collision Warning System For Automotive Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
